1. Home
  2. ADMA vs CLM Comparison

ADMA vs CLM Comparison

Compare ADMA & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

N/A

Current Price

$11.40

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Cornerstone Strategic Value Fund Inc. New

CLM

Cornerstone Strategic Value Fund Inc. New

N/A

Current Price

$6.02

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ADMA
CLM
Founded
2004
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2012
1995

Fundamental Metrics

Financial Performance
Metric
ADMA
CLM
Price
$11.40
$6.02
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $17.00
N/A
AVG Volume (30 Days)
★ 2.7M
2.6M
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.35
N/A
Revenue
★ $42,219,783.00
N/A
Revenue This Year
$4.93
N/A
Revenue Next Year
$17.59
N/A
P/E Ratio
$33.37
★ N/A
Revenue Growth
★ 43.85
N/A
52 Week Low
$7.21
$5.56
52 Week High
$20.46
$8.53

Technical Indicators

Market Signals
Indicator
ADMA
CLM
Relative Strength Index (RSI) 64.81 37.75
Support Level $10.57 N/A
Resistance Level $16.58 $7.73
Average True Range (ATR) 0.37 0.16
MACD 0.05 -0.02
Stochastic Oscillator 75.73 38.68

Price Performance

Historical Comparison
ADMA
CLM

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, Consumer Staples, utilities, energy, Real Estate, materials, and other sectors.

Share on Social Networks: